Opiant Pharmaceuticals, Inc. (OPNT) Social Stream
OPIANT PHARMACEUTICALS INC (OPNT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering OPNT.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 23 months, OPNT's average price target has gone down $13.66.
Over the past 47 weeks, OPNT's average upside potential has been 166.02%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
OPNT Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 26 weeks, OPNT's average broker recommendation rating worsened by 2.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, OPIANT PHARMACEUTICALS INC's number of analysts covering the stock is higher than 45.99% of them.
- OPNT has a higher average analyst price target than 849.52% of stocks in the micro market cap category.
- OPIANT PHARMACEUTICALS INC's variance in analysts' estimates is lower than -49.66% of Healthcare stocks.
- In terms of how OPIANT PHARMACEUTICALS INC fares relative to Non-Metallic and Industrial Metal Mining stocks, note that its upside potential (average analyst target price relative to current price) is greater than 756.46% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Non-Metallic and Industrial Metal Mining industry with the ratings most similar to OPIANT PHARMACEUTICALS INC are AAU, ASM, and SVBL.
View All Top Stocks by Price Target
Is OPNT a Buy, Hold or Sell? See the POWR Ratings now!